CurrentRheuma
Get Weekly

Topic · page 3 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 81–120 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. J Rheumatol

    What Affects Care Complexity in Rheumatoid Arthritis? An Integrative Review of Complexity Domains and Associated Patient and Health System Outcomes

    Research article

  2. J Rheumatol

    Association of Intraerosive Power Doppler Signals Detected by Musculoskeletal Ultrasound With 1-Year Radiographic Progression in Early Rheumatoid Arthritis

    Cohort study

  3. Semin Arthritis Rheum

    Definition and prevalence of residual disease in inflammatory arthritis: a systematic literature review and meta-analysis

    Meta-analysis

  4. Joint Bone Spine

    Direct and indirect costs of rheumatoid arthritis and related conditions in France: a 2015–2023 nation-wide population-based study

    Cohort study

  5. RMD Open

    Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis

    Cohort study

  6. Arthritis Rheumatol

    Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

    Cohort study

  7. Ann Rheum Dis

    A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trial

    Randomized controlled trial

  8. RMD Open

    Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study

    Cohort study

  9. Arthritis Res Ther

    DAS28-ESR may underestimate disease activity in rheumatoid arthritis patients with nonalcoholic fatty liver disease: a retrospective cohort study

    Cohort study

  10. RMD Open

    Treat-to-target strategies are feasible in elderly-onset rheumatoid arthritis given its reassuring risk–benefit profile

    Secondary analysis

  11. RMD Open

    Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency

    Cross-sectional study

  12. RMD Open

    Prevalence of sarcopenia in patients with rheumatoid arthritis: a cross-sectional study

    Cross-sectional study

  13. Lancet Rheumatol

    Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial

    Randomized controlled trial

  14. Semin Arthritis Rheum

    Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy

    Guideline or statement

  15. Rheumatology (Oxford)

    Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials

    Meta-analysis

  16. RMD Open

    Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis

    Cohort study

  17. RMD Open

    Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study

    Randomized controlled trial

  18. RMD Open

    Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analyses

    Meta-analysis

  19. Rheumatology (Oxford)

    Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases

    Mechanistic study

  20. Rheumatology (Oxford)

    CAR-T as a salvage treatment in polyrefractory RA

    Cohort study

  21. Ann Rheum Dis

    Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year study

    Cohort study

  22. RMD Open

    Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry

    Cohort study

  23. Rheumatology (Oxford)

    Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries

    Cohort study

  24. RMD Open

    First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients

    Randomized controlled trial

  25. Arthritis Care Res (Hoboken)

    Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

    Cohort study

  26. Arthritis Rheumatol

    Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

    Mechanistic study

  27. Arthritis Rheumatol

    The Role of IgM Anti‐acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis

    Mechanistic study

  28. Arthritis Rheumatol

    Increased Plasma Microbial tDR ‐1 in At‐Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response

    Case-control study

  29. Ann Rheum Dis

    Predictors of unacceptable pain and the impact of sociodemographic factors and comorbidities—results from a large, nationwide cohort of early rheumatoid arthritis

    Cohort study

  30. Scand J Rheumatol

    Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study

    Cohort study

  31. Semin Arthritis Rheum

    Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort

    Cohort study

  32. Arthritis Res Ther

    Sputum lautropia is decreased in rheumatoid arthritis-associated pulmonary fibrosis

    Cross-sectional study

  33. Rheumatology (Oxford)

    Frailty in rheumatoid arthritis and the general population: a cross-sectional analysis of the Groningen Frailty Indicator and Fried criteria

    Cross-sectional study

  34. RMD Open

    Elevated plasma monounsaturated fatty acids and their associations with disease activity, adiposity and sex in patients with rheumatoid arthritis: a cross-sectional study

    Cross-sectional study

  35. Rheumatology (Oxford)

    From disability to daily life: functional status, quality of life and work productivity in real-world inflammatory arthritis

    Cross-sectional study

  36. Semin Arthritis Rheum

    Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance

    Meta-analysis

  37. Ann Rheum Dis

    Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy

    Mechanistic study

  38. Rheumatology (Oxford)

    T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice

    Mechanistic study

  39. Joint Bone Spine

    Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials

    Secondary analysis

  40. Rheumatology (Oxford)

    Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis

    Cohort study

All 1,564 Briefs in ExploreShowing Briefs 81–120 of 1,564, newest first